ATE181422T1 - Verfahren zur diagnose von praeklampsie - Google Patents

Verfahren zur diagnose von praeklampsie

Info

Publication number
ATE181422T1
ATE181422T1 AT95913568T AT95913568T ATE181422T1 AT E181422 T1 ATE181422 T1 AT E181422T1 AT 95913568 T AT95913568 T AT 95913568T AT 95913568 T AT95913568 T AT 95913568T AT E181422 T1 ATE181422 T1 AT E181422T1
Authority
AT
Austria
Prior art keywords
preeclampsia
diagnosis
csf
methods
patients
Prior art date
Application number
AT95913568T
Other languages
English (en)
Inventor
James C Keith Jr
Original Assignee
Genetics Inst
Virginia Polytechnic Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, Virginia Polytechnic Inst filed Critical Genetics Inst
Application granted granted Critical
Publication of ATE181422T1 publication Critical patent/ATE181422T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2073—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95913568T 1994-03-10 1995-03-10 Verfahren zur diagnose von praeklampsie ATE181422T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/212,446 US5543138A (en) 1994-03-10 1994-03-10 Methods of diagnosing and treating preeclampsia

Publications (1)

Publication Number Publication Date
ATE181422T1 true ATE181422T1 (de) 1999-07-15

Family

ID=22791053

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95913568T ATE181422T1 (de) 1994-03-10 1995-03-10 Verfahren zur diagnose von praeklampsie

Country Status (12)

Country Link
US (2) US5543138A (de)
EP (1) EP0749582B1 (de)
JP (2) JP4149512B2 (de)
KR (1) KR100350259B1 (de)
AT (1) ATE181422T1 (de)
AU (1) AU682593B2 (de)
CA (1) CA2184920C (de)
DE (1) DE69510336T2 (de)
DK (1) DK0749582T3 (de)
ES (1) ES2138729T3 (de)
GR (1) GR3031250T3 (de)
WO (1) WO1995024650A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6540993B1 (en) 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11
US5679339A (en) * 1995-06-27 1997-10-21 Keith; James Method of using IL-11 for treating spondyloarthropies
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
AUPO439396A0 (en) * 1996-12-24 1997-01-23 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
AU739063B2 (en) * 1996-12-24 2001-10-04 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
GB9927125D0 (en) * 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
US6642055B1 (en) 2000-03-31 2003-11-04 Arbogast Pharmaceuticals, Inc. Method for the prediction of preeclampsia and other diseases
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
US7335362B2 (en) * 2002-07-19 2008-02-26 Beth Israel Deaconess Medical Center Methods of treating pre-eclampsia or eclampsia
DK2308507T3 (da) * 2002-07-19 2015-04-20 Beth Israel Hospital Fremgangsmåder til behandling af præeklampsi
AU2004210650C1 (en) * 2003-02-04 2010-01-14 The Administrators Of The Tulane Educational Fund Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
ES2556164T3 (es) * 2003-09-23 2016-01-13 The General Hospital Corporation Cribado de la preeclampsia
US8273383B2 (en) * 2004-05-04 2012-09-25 Children's Medical Center Corporation Methods and compositions for treatment of preeclampsia
US20060024677A1 (en) * 2004-07-20 2006-02-02 Morris David W Novel therapeutic targets in cancer
DK1804836T3 (da) 2004-09-24 2011-01-24 Beth Israel Hospital Fremgangsmåder til diagnosticering og behandling af graviditetskomplikationer
US7740849B2 (en) * 2004-09-24 2010-06-22 Beth Israel Deaconess Medical Center Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
JP2008523816A (ja) * 2004-12-15 2008-07-10 ベス イスラエル ディーコネス メディカル センター 妊娠合併症の診断および処置に有用な核酸およびポリペプチド
US20060212484A1 (en) * 2005-03-18 2006-09-21 Chaffin David G Jr System and method for evaluating, monitoring, diagnosing, and treating hypertension and other medical disorders
US20090286271A1 (en) * 2006-05-31 2009-11-19 Karumanchi Ananth S Methods of Diagnosing and Treating Complications of Pregnancy
CA2950287C (en) 2008-12-19 2020-03-24 Syngenta Crop Protection Ag Materials and methods for controlling nematodes with pasteuria spores in seed coatings

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198366A (en) * 1986-03-23 1993-03-30 Technion Research & Development Foundation Ltd. Method for the detection of pregnancy disorders
US4879227A (en) * 1986-05-06 1989-11-07 Genetics Institute, Inc. Production of a recombinant human colony stimulating factor
US4868119A (en) * 1986-12-11 1989-09-19 Genetics Institute, Inc. Hematopoietic growth factors
US5079171A (en) * 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
EP0440750A4 (en) * 1988-12-14 1991-10-09 The Regents Of The University Of California Diagnostic assay for the detection of preeclampsia
US5211947A (en) * 1988-12-16 1993-05-18 Schering Corporation Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor
JP3222135B2 (ja) * 1991-11-04 2001-10-22 アデザ バイオメディカル コーポレイション 早期分娩の危険が増大している女性を特定するスクリーニング方法

Also Published As

Publication number Publication date
JP2004029031A (ja) 2004-01-29
WO1995024650A3 (en) 1995-10-05
CA2184920A1 (en) 1995-09-14
JPH09510292A (ja) 1997-10-14
DK0749582T3 (da) 1999-11-22
DE69510336T2 (de) 2000-02-24
ES2138729T3 (es) 2000-01-16
CA2184920C (en) 2007-10-30
DE69510336D1 (de) 1999-07-22
US5543138A (en) 1996-08-06
GR3031250T3 (en) 1999-12-31
WO1995024650A2 (en) 1995-09-14
JP4149512B2 (ja) 2008-09-10
US5580554A (en) 1996-12-03
KR100350259B1 (ko) 2002-10-18
JP3741697B2 (ja) 2006-02-01
AU2095495A (en) 1995-09-25
EP0749582A1 (de) 1996-12-27
AU682593B2 (en) 1997-10-09
EP0749582B1 (de) 1999-06-16

Similar Documents

Publication Publication Date Title
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
DE68918223D1 (de) Blutfilter, Verfahren und Vorrichtung für hemorheologische Messungen.
DE3879218D1 (de) Medizinisches instrument und verfahren zur herstellung.
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
DE3855525D1 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
DE68922874D1 (de) Verfahren und Gerät zur Blutdruckmessung.
DE3889346D1 (de) Mittel zur Arzneistoffabgabe und Verfahren zu deren Herstellung.
DE3764253D1 (de) Medizinischer saugkoerper mit roentgenkontrastmittel und verfahren zu seiner herstellung.
DE69510810D1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DE3689943D1 (de) Degradierte Spezies eines Gewebeplasminogenaktivators, pharmazeutische Zubereitung und Verfahren zur Herstellung derselben.
DE69725606D1 (de) Methoden für die diagnose von allergischen atemwegsaspergillosen
ATE234466T1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
DE69018840D1 (de) Verfahren und Vorrichtung zur Bestimmung des mittleren arteriellen Blutdruckes.
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
DE3885304D1 (de) Zubereitung für zahnbehandlung und verfahren zur herstellung.
DE69719930D1 (de) Verfahren zur Herstellung von medizinischen Pflastern zur perkutanen Verabreichung, und Vorrichtung dafür
EP0057236A4 (de) Verfahren zum feststellen der tumorgebundenen glukoseseitenkette, verfahren zur diagnose von tumoren sowie "kit" dazu.
FR2608767B1 (fr) Procede pour la detection et le dosage des anticorps anti-(sporozoaires de p. falciparum) dans le sang humain et trousses de diagnostic pour mettre en oeuvre ce procede
HUP9903688A2 (hu) Olanzapin alkalmazása az autizmus kezelésére szolgáló gyógyszerkészítmény előállítására
DE3785175D1 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
DE69013139D1 (de) Mittel zur Vorbeugung, Diagnose und Therapie von rheumatischen, autoimmunen, Haut- und Bindegewebekrankheiten von unbekannter Aetiologie und Verfahren zu seiner Herstellung und Verwendung.
AT386079B (de) Verfahren zum nachweis von antikoerpern, und mittel zum nachweis von antikoerpern und verfahren zur herstellung des mittels
DE3884391D1 (de) Verfahren zur integrierten onkologischen eingangsuntersuchung und krebstherapie.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEFA Change of the company name